NFLECTION THERAPEUTICS

NFlection is a biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi and nevus sebaceous. To address these rare disorders, which are also referred to as RASopathies because they are driven by the aberrant activation of the Ras/Raf/MEK/ERK pathway, NFlection develops first-in-class MEK (mitogen-activated protein kinase kinase) inhibitors as topical treatments.

#SimilarOrganizations #People #Financial #Website #More

NFLECTION THERAPEUTICS

Industry:

Biotechnology Medical Therapeutics

Founded:

2014-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.nflectionrx.com

Total Employee:

1+

Status:

Active

Contact:

617-875-4559

Total Funding:

41.4 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aptitude-medical-systems-logo

Aptitude Medical Systems

Aptitude Medical Systems focuses on the potential of aptamers to solve the fundamental problems of antibodies.

hepatx-logo

HepaTx

Hepatx is developing regenerative medicine solutions.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

zavante-therapeutics-logo

Zavante Therapeutics

Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.

Current Employees Featured

christopher-powala_image

Christopher Powala
Christopher Powala President & Chief Eexecutive Officer @ NFlection Therapeutics
President & Chief Eexecutive Officer
2019-06-01

mike-wootton_image

Mike Wootton
Mike Wootton Co-Founder and Chief Executive Officer @ NFlection Therapeutics
Co-Founder and Chief Executive Officer

Founder

mike-wootton_image

Mike Wootton

Investors List

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series A - NFlection Therapeutics

venbio_image

venBio Partners

venBio Partners investment in Series A - NFlection Therapeutics

eight-roads-ventures_image

Eight Roads Ventures

Eight Roads Ventures investment in Venture Round - NFlection Therapeutics

Official Site Inspections

http://www.nflectionrx.com

Host Informations
Whois Informations

Loading ...

More informations about "NFlection Therapeutics" on Search Engine